on EBD Group
Biotech Showcase™ 2026: A Hub for Global Biopharma Leaders
Biotech Showcase™ 2026 is set to return to San Francisco during J.P. Morgan Healthcare Week from January 12-14, with a virtual component on January 21-22. The event continues its 19-year tradition as a pivotal meeting point for over 3,200 global biopharmaceutical professionals and 1,200 life sciences investors. Participants include companies such as PhRMA, BIO, Novo, Ipsen, Regeneron, and Sofinnova Investments.
Attendees will have the opportunity to engage in one-to-one meetings, corporate presentations, and networking sessions. The event also integrates with the TechBio and Seed Showcases, offering a broad spectrum of life science innovations. Virtual attendees will have access to company showcases and session recordings.
The 2026 agenda focuses on industry trends including AI in healthcare, biopharma financing, and the future of healthcare access and equity. A projected 6,000+ one-to-one meetings highlight the event's role in facilitating deal-making and industry growth.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all EBD Group news